InvestorsHub Logo
Followers 65
Posts 10321
Boards Moderated 3
Alias Born 06/30/2004

Re: None

Friday, 02/03/2006 11:19:51 AM

Friday, February 03, 2006 11:19:51 AM

Post# of 346056
PPHM hitting various "exposure" sources...

(Like Ken said, this board will likely get even busier ... great board by the way, you folks provide incredible DD information)

bellwetherreport.com: The Bellwether Report begins to follow Peregrine Pharmaceuticals Inc

--------------------------------------------------------------------------------

M2
11:09 a.m. 02/03/2006


Feb 03, 2006 (M2 PRESSWIRE via COMTEX) -- Today the Bellwether Report has identified Peregrine Pharmaceuticals Inc. (PPHM), a company that our analysts will be tracking over the ensuing weeks. They recently came out with a significant corporate development this month, causing a positive correction. For a full report on the below mentioned company, and many more, feel free to visit www.bellwetherreport.com for a free 30 day no obligation trial.

Peregrine Pharmaceuticals has gained a bit today February 02/06. Unlike its namesake the Peregrine Falcon which is an endangered species this Peregrine means to be a survivor. The company was founded in 1981 under the name, Techniclone International Corp., after a merger with & into Techniclone Corp. the company changed its name to Peregrine Pharmaceuticals Inc. in 2000. In March 1987 Peregrine found it necessary to effect a 1 - 100 reverse stock split.

Peregrine Pharmaceuticals, Inc. on January 18/06 announced that the U.S. Department of Defense (DOD) has awarded a grant totaling $585,000 to its collaborators at the University of Texas Southwestern Medical Center at Dallas to conduct preclinical studies of Tarvacin(TM) Anti-Cancer as a potential treatment for prostate cancer. Tarvacin Anti-Cancer, Peregrine's lead vascular targeting antibody, is currently in a Phase I clinical trial for advanced refractory solid tumors.

In November, Peregrine announced a major DOD prostate cancer grant to UT Southwestern researchers for preclinical studies of Tarvacin in combination with chemotherapy.

With this new project, the total.....

To view the full unbiased report on Peregrine Pharmaceuticals Inc. (PPHM), feel free to visit our site.


Yorkville / Cornell Tracking Board #board-9964


"I can think of no more valuable commodity than information"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News